fleroxacin has been researched along with Disease Models, Animal in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Bartlett, MS; Fishman, JA; Queener, SF; Roth, RS | 1 |
Cleeland, R; Costerton, JW; Lam, K; McKay, SG; Morck, DW; Olson, ME; Prosser, B | 1 |
Saito, H; Sato, K; Tomioka, H | 1 |
Auckenthaler, R; Chuard, C; Herrmann, M; Lew, DP; Lucet, JC; Rohner, P; Waldvogel, FA | 1 |
Auckenthaler, R; Herrmann, M; Lew, DP; Lucet, JC; Rohner, P; Waldvogel, FA | 1 |
Barzilai, A; Keren, G; Leibovitz, E; Rubinstein, E; Shabtai, M | 1 |
Burdon, DW; Keighley, MR; Tudor, RG; Yoshioka, K; Youngs, DJ | 1 |
8 other study(ies) available for fleroxacin and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model.
Topics: Animals; Disease Models, Animal; Fleroxacin; Mice; Mice, Inbred BALB C; Mice, SCID; Pneumocystis; Pneumocystis Infections; Pneumonia, Pneumocystis; Teniposide; Topoisomerase II Inhibitors | 1993 |
Therapeutic efficacy of fleroxacin for eliminating catheter-associated urinary tract infection in a rabbit model.
Topics: Animals; Catheters, Indwelling; Disease Models, Animal; Escherichia coli Infections; Fleroxacin; Male; Rabbits; Random Allocation; Urinary Catheterization; Urinary Tract Infections | 1993 |
Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteria.
Topics: Animals; Disease Models, Animal; Female; Fleroxacin; Leprosy; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Ofloxacin | 1991 |
Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Diffusion Chambers, Culture; Disease Models, Animal; Drug Resistance, Microbial; Fleroxacin; Foreign Bodies; Gentamicins; Kinetics; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1991 |
Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Fleroxacin; Foreign-Body Reaction; Male; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1990 |
The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model.
Topics: Abscess; Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Enterobacteriaceae Infections; Female; Fleroxacin; Half-Life; Pefloxacin; Rats; Serratia marcescens | 1989 |
A comparison of the penetration of two quinolones into intra-abdominal abscess.
Topics: Abdomen; Abscess; Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Fleroxacin; Injections, Intravenous; Male; Permeability; Rats; Rats, Inbred Strains; Time Factors; Tissue Distribution | 1988 |